Evidence-based clinical review CGRP-Targeted Migraine Prevention as a First-Line Option: A Family Medicine Prescribing Framework Reconciling AHS and ACP guidance, selecting oral, injectable, and infusion therapies, and monitoring the updated 2026 safety warnings Estimated reading time: 17 minutes
Tag: erenumab
